14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
Jan 20, 2016 $3.46 $3.81 $3.34 $3.70 348 200
Jan 19, 2016 $3.67 $3.68 $3.38 $3.51 265 600
Jan 15, 2016 $3.40 $3.67 $3.31 $3.63 223 700
Jan 14, 2016 $3.42 $3.63 $3.10 $3.50 165 100
Jan 13, 2016 $3.78 $3.92 $3.38 $3.42 190 800
Jan 12, 2016 $3.92 $4.15 $3.60 $3.78 211 800
Jan 11, 2016 $4.19 $4.27 $3.84 $3.90 253 200
Jan 08, 2016 $4.38 $4.49 $4.11 $4.13 171 000
Jan 07, 2016 $4.57 $4.60 $4.35 $4.36 121 100
Jan 06, 2016 $5.01 $5.06 $4.57 $4.69 150 600
Jan 05, 2016 $5.11 $5.23 $5.03 $5.08 59 900
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT